Gene: PRR15

222171
-
proline rich 15
protein-coding
7p14.3
Ensembl:ENSG00000176532 Vega:OTTHUMG00000128555 UniprotKB:Q8IV56
NC_000007.14
PubMed
ND
1   
NA (AD)  NA (ND)   (Frontal_Cortex)
5.973e-1 (AD)  9.963e-1 (ND)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg18451588chr7:29606289PRR159.300e-18Smoking27651444
cg10580293chr7:29605897PRR152.100e-15Smoking27651444
cg06868100chr7:29606349PRR151.700e-14Smoking27651444
cg08900404chr7:29605808PRR153.400e-10Smoking27651444
cg23363754chr7:29606082PRR151.000e-9Smoking27651444
cg09635954chr7:29605624PRR152.000e-9Smoking27651444

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OLFML2B0.618
GLRX0.532
TIFA0.531
PLEKHA8P10.515
UHRF20.51
GPRIN30.509
FAM43A0.508
DPP40.502
PLXDC20.501
SHB0.5

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
PON1-0.421
MRO-0.417
ALDH1L1-AS2-0.403
SLC13A5-0.393
ACBD7-0.392
TNS3-0.388
APCDD1-0.38
GPAM-0.365
CABLES1-0.362
NWD1-0.359

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C5486512-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of PRR15 mRNA19933214
C0065512-amino-2-methyl-1-propanol2-amino-2-methyl-1-propanol results in decreased expression of PRR15 mRNA25088246
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
C487081belinostat"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
D001564Benzo(a)pyreneBenzo(a)pyrene results in increased expression of PRR15 mRNA19770486|2171566
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PRR15 mRNA"19150397
C038328BEP protocolBEP protocol results in increased expression of PRR15 mRNA18987330
C095105bexarotene[bexarotene co-treated with Tamoxifen] results in increased expression of PRR15 mRNA17630414
C006780bisphenol Abisphenol A results in decreased expression of PRR15 mRNA27685785
C006780bisphenol A[bisphenol A co-treated with Testosterone] results in increased expression of PRR15 mRNA26496021
C006780bisphenol Abisphenol A results in increased expression of PRR15 mRNA25181051
C006780bisphenol Abisphenol A results in increased methylation of PRR15 gene28505145
D002737ChloropreneChloroprene results in decreased expression of PRR15 mRNA23125180
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRR15 gene20938992
C074702chromium hexavalent ionchromium hexavalent ion affects the expression of PRR15 mRNA28472532
D003300Copper[Copper co-treated with Dietary Sucrose] results in decreased expression of PRR15 mRNA26033743
D003375CoumestrolCoumestrol results in decreased expression of PRR15 mRNA19167446
D016572CyclosporineCyclosporine results in decreased expression of PRR15 mRNA25562108
D016572CyclosporineCyclosporine results in decreased expression of PRR15 mRNA19770486
D016572CyclosporineCyclosporine results in increased expression of PRR15 protein25047351
D003999Dichloroacetic AcidDichloroacetic Acid results in increased expression of PRR15 mRNA28962523
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in increased expression of PRR15 mRNA27392435
D019422Dietary Sucrose[Copper co-treated with Dietary Sucrose] results in decreased expression of PRR15 mRNA26033743
D019422Dietary SucroseDietary Sucrose results in decreased expression of PRR15 mRNA26033743
C118739entinostatentinostat results in increased expression of PRR15 mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRR15 gene20938992
C004312glycidolglycidol results in increased expression of PRR15 mRNA24915197
C412815GW 4064GW 4064 results in decreased expression of PRR15 mRNA26655953
D015759Ionomycin[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of PRR15 mRNA25613284
C544151jinfukang[Cisplatin co-treated with jinfukang] results in increased expression of PRR15 mRNA27392435
C544151jinfukangjinfukang results in increased expression of PRR15 mRNA27392435
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of PRR15 mRNA27432991
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of PRR15 gene20938992
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of PRR15 mRNA"25554681
D010100OxygenOxygen deficiency results in increased expression of PRR15 mRNA20880076
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of PRR15 mRNA26272509
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PRR15 mRNA19710929
D011374ProgesteroneProgesterone results in increased expression of PRR15 mRNA23012394|2301818
D011374ProgesteroneProgesterone results in increased expression of PRR15 mRNA20864642
D011374ProgesteroneProgesterone results in decreased expression of PRR15 mRNA19690047
D011441PropylthiouracilPropylthiouracil results in increased expression of PRR15 mRNA24780913
D011794QuercetinQuercetin results in decreased expression of PRR15 mRNA21632981
C009250sevofluranesevoflurane results in decreased expression of PRR15 mRNA26206149
D012822Silicon DioxideSilicon Dioxide analog results in decreased expression of PRR15 mRNA23806026|2589566
C009277sodium arsenatesodium arsenate results in decreased expression of PRR15 mRNA21795629
C017947sodium arsenitesodium arsenite results in decreased expression of PRR15 mRNA28595984
D013629Tamoxifen[bexarotene co-treated with Tamoxifen] results in increased expression of PRR15 mRNA17630414
D013739Testosterone[bisphenol A co-treated with Testosterone] results in increased expression of PRR15 mRNA26496021
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of PRR15 mRNA20106945|2163298
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of PRR15 mRNA26377647
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of PRR15 mRNA19933214
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of PRR15 mRNA19770486|2629044
D013755Tetradecanoylphorbol Acetate[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of PRR15 mRNA25613284
C009495titanium dioxidetitanium dioxide results in increased expression of PRR15 mRNA23557971
D014028Tobacco Smoke PollutionTobacco Smoke Pollution results in decreased methylation of PRR15 gene26756918
D014520UrethaneUrethane results in decreased expression of PRR15 mRNA28818685
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PRR15 mRNA"27188386
D014635Valproic AcidValproic Acid results in increased expression of PRR15 mRNA23179753|2438349

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO ID GO Term Qualifier Evidence PubMed
GO:0007275multicellular organism development-IEA-  
GO ID GO Term Qualifier Evidence PubMed
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal
29796116Genome-wide analysis of DNA methylation in bronchial washings. (2018)Um SWClin Epigenetics